Carregant...
In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D
AIM: There is controversy regarding the potential fitness costs of rifampicin (RIF) resistance-conferring mutations in the Mycobacterium tuberculosis (Mtb) rpoB gene. We characterized the pathogenicity of an Mtb RpoB H526D mutant. MATERIALS & METHODS: A mutant containing the RpoB H526D mutation...
Guardat en:
| Publicat a: | Future Microbiol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5506874/ https://ncbi.nlm.nih.gov/pubmed/28343421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb-2017-0022 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|